|
Market Cap (22-Jun) $292,012,800 (943rd) |
Close (30-Jun) $0.350 |
Volume (30-Jun) 313,271 |
Shortsold (6-Jun) 238,849 (0.10%) (425th) |
|
52w High $1.79 |
52w Low $0.350 |
P/E - |
EPS -0.02 |
OCC released this announcement to the ASX on 11 August 2021, 16:54. The announcement is not marked as price sensitive, and is 2 page(s) in length and 146.26kb in size.
You can view all announcements from OCC and see how they appear on a price chart on the announcements page.
At the date of this announcement, OCC was 0.108% short sold according to ASIC data. It was ranked the 445th most shorted stock on the ASX. It is now ranked as the 425th most shorted stock on the ASX with 0.099% of total shares short sold as of the latest reported data (06 June 2025).
| Other Recent Announcements from OCC | |
|---|---|
| Orthocell receives A$3.17m R&D tax incentive refund | 21 June 2023, 9:00 |
| Change of Director's Interest Notice - Paul Anderson | 16 June 2023, 9:08 |
| Change of Director's Interest Notice - Paul Anderson | 13 June 2023, 9:25 |
| Notice under Section 708(A) of the Corporations Act | 11 August 2021, 16:54 |
| Application for quotation of securities - OCC | 11 August 2021, 16:53 |
| CelGro Facilitates Lymphatic Vessel Regeneration Updated | 2 August 2021, 13:51 |
| CelGro Facilitates Lymphatic Vessel Regeneration | 2 August 2021, 9:20 |
You must be logged in to post a reply.
Orthocell 